期刊文献+

胶质瘤中NF-κB、CyclinD1的表达及意义 被引量:3

Significance of NF-κB and CyclinD1 Expression in the Gliomas
下载PDF
导出
摘要 [目的]探讨NF κB、cyclinD1在胶质瘤中的表达及意义。[方法]应用免疫组织化学方法检测NF κBp65、cyclinD1在45例胶质瘤组织及10例正常大脑组织中的表达情况。[结果]胶质瘤中NF κBp65蛋白阳性表达率为60.0 % (27/45) ,cyclinD1阳性率为42.2% (19/45) ,10例正常脑组织中NF κBp65、CyclinD1无1例阳性表达。NF κBp65、CyclinD1表达与胶质瘤的恶性程度有关。NF κBp65表达与CyclinD1表达呈显著正相关。[结论]NF κBp65是与胶质瘤相关的新的癌蛋白 ,NF κBp65上调CyclinD1的表达 ,可导致胶质瘤的发生。 Purpose To evaluate the significance of NF-κB and cyclinD1 protein expression and their relationship in the gliomas. The expressions of NF-κB p65 protein,cyclinD1 protein in 45 cases of gliomas and 10 cases of normal brain tissues were studied immunohistochemically. None of the normal tissues exhibited NF-κB p65, cyclinD1 protein .In contrast, 27 of 45 glioma specimens were positive for NF-κB p65 protein with a 60.0% positive rate (P<0.01), and 19 of 45 glioma specimens were positive for cyclinD1 protein with a 42.2% positive rate (P<0.01).The NF-κB p65 protein and cyclinD1 protein expression were correlated to the differentiation (P<0.05).The expression of NF-κB p65 was closely related with the expression of cyclinD1. [Conclusion] NF-κB p65 is a new oncogenic protein related to the gliomas. NF-κB p65 up-regulates the expression of cyclinD1, then lead to tumor occurrence.
出处 《肿瘤学杂志》 CAS 2003年第1期16-18,共3页 Journal of Chinese Oncology
关键词 核因子-KB 细胞周期素 胶质瘤 免疫组织化学 nuclear factor-kappa B cyclin glioma immunohistochemistry
  • 相关文献

参考文献1

二级参考文献7

  • 1Takahashi Y,Kitadai Y,Bueana CD,et al.Expression of VEGF and its receptor, KDR, correlation with vascularity,metastasis and proliferation of human colon cancer[].Cancer Research.1995
  • 2Wang W,Abbruzzese JL,Evans DB,et al.The nuclear factor-κB relA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells[].Clinical Cancer Research.1999
  • 3Yoshida S,Ono M,Shono T,et al.Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis[].Molecular and Cellular Biology.1997
  • 4Beck L Jr,D′Amore DP.Vascular development: cellular and molecular regulation[].The FASEB Journal.1997
  • 5Folkman J.What is the evidence that tumors are angiogenesis dependent[].Journal of the National Cancer Institute.1990
  • 6Breier G,Risau W.The role of vascular endothelial growth factor in blood vessel formation[].Trends in Cell Biology.1996
  • 7Hamahan D,Folkman J.Patterns and emerging mechanisms of the angiogenesis switch during tumorgenesis[].Cell.1997

共引文献9

同被引文献34

  • 1Cailin Chen,Leonard C.Edelstein,et al.The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL[J].Mole Cell Biol,2000,20(8):2687-2695.
  • 2Chiao PJ,Na R,Niu,J et al.Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells[J].Cancer,2002,95(8):1696-705.
  • 3Wang W,Abbruzzese JL,Evans DB,et al.The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells[J].Clin Cancer Res,1999,5(1):119-27.
  • 4Miyamoto Y,Hosotani R,Wada M,et al.Iunohistochemical analysis of Bcl-2,Bax,Bcl-x,and Mcl-1 expression in pancreatic cancers[J].Oncology,1999,56(1):73-82.
  • 5Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis:a new significant and independent prognostic indicator in early stage breast carcinoma[J]. J Natl Cancer Invest, 1992,84:1875.
  • 6Maeda K, Chung Y, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma[J]. Cancer, 1996,77:858.
  • 7Mercurio F, Manning AM. Mutiple signals convering on NF-κb[J]. Current Opinion in Cell Biology, 1999,11(2):226.
  • 8Miyamoto S, Chiao Pj, Verma I M. Enhanced IκBα degradation is responsible for constitutive activity in maturemurine B-cell lines[J]. Mol cell Biol, 1994,14(5):3276.
  • 9Tanigawa N, Amaya H, Matsumura M, et al. Correlation between expression of vascular endothelial growth factor and tumor vascularity and patient outcome in human gastric carcinoma[J]. J Clin Oncol, 1997,15(2) :826.
  • 10Eck SL,Alavi JB,Alavi A,et al. Treatment of advanced CNS malignancies with the recombinant adenovious 1-15. 010 RSYTK: a phase I trial [J]. Hum Gene Ther, 1996,7 (12) : 1465-1482.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部